Scaffold Technology Market Worth $1.94 Billion By 2027

The global scaffold technology market size is expected to reach USD 1.94 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.05% from 2020 to 2027. Constant technological advancements in scaffold technology, such as the advent of micropatterned surface microplates and nanofiber-based scaffolds, to facilitate wound repair and soft tissue repair applications boost the revenue generation in the market. A recently developed next-generation injectable microporous scaffold enables organ-on-a-chip technology for the enhancement of in vivo wound healing procedures.

The commercial success of 3D cell culture over the 2D culture system for histological analysis and drug screening purposes has provided lucrative growth avenues for scaffold technology used during 3D cell culturing. This technology minimizes the usage of animal models as it reiterates tissue architectures, thus providing physiologically relevant cellular models for disease investigation.

The broadening horizon of scaffold technology in drug development procedures fuels the market progression. The continual attrition rate in drug development caused due to the inability of monolayer cell culture paves a path for the adoption of scaffold-based cultures that efficiently mimic the disease-causing microenvironment. The rise in demand for novel scaffold-based cultures also reduces the loss of enormous costs involved in the failure of drug development.

The use of biomatrix with incorporated nanoparticles for drug delivery and tissue repair is expected to have a high success rate in the near future. The stem cell therapy, regenerative medicine, and tissue engineering application dominated the market in 2019. The combination of biomaterials and stem cells is an emerging concept useful in cell delivery and tissue construction, which positively impacts the revenue generation in this application. In addition, the presence of supportive organizations, such as the International Society for Stem Cell Research, boosts the demand for 3D scaffolds in this application.

For instance, in May 2019, InVivo Therapeutics introduced a new trial for its neuro-spinal scaffold device, INSPIRE 2.0 study, which widened the scope of a biodegradable device in the treatment of thoracic spinal cord injury. A rise in the number of drug approvals and growth in R&D funding prompt the biotechnology and pharmaceutical companies to widely employ 3D culturing techniques. These techniques act as a robust tool in toxicology and metabolic profiling of drug moieties during the drug development processes.

Asia Pacific is anticipated to expand at the fastest CAGR over the forecast period. Tianjin Municipal Science and Technology Commission and Administrative Commission of the Tianjin Economic-Technological Development Area are China-based funding bodies that boost cell-based research projects in China. For instance, in October 2019, Corning launched Elplasia and Matrigel matrix for organoid culture to support organoid and spheroid culture models, thereby expanding its cell culture portfolio.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/scaffold-technology-market

Further key findings from the report suggest:

By type, nanofiber-based scaffolds are expected to register the fastest growth rate during the forecast period with the expansion of nanoscience and nanotechnology technologies
The stem cell therapy, regenerative medicine, and tissue engineering application segment accounted for the largest revenue share in 2019 and is expected to grow at a lucrative pace in the near future
Stem cell therapy and regenerative medicine are transforming the treatment of neurodegenerative disorders, resulting in the fastest CAGR of the neurology segment
The Asia Pacific is anticipated to witness the fastest growth over the forecast period due to the rise in the number of research grants for cell-based research and tissue engineering projects in this region
Key players such as Merck, Thermo Fisher, Corning, Avacta, Medtronic, Pelobiotech, and Matricel GmbH, have adopted several strategic initiatives to reinforce their market presence

Scaffold Technology Market Size Worth $1.5 Billion By 2024

The global scaffold technology market size is anticipated to reach USD 1.5 billion by 2024, according to a new report by Grand View Research, Inc. The evolution of scaffold technology, which facilitates the transplantation process, has created opportunities to address tissue engineering-associated challenges such as vascularization. Also, scaffolds are used in the treatment of damaged and diseased organs or tissues to provide support to implants that are surgically inserted into the patient’s body. This is expected to further support the emergence of this vertical.

Rise in the aging population and the number of organ defunctionalization cases coupled with the demand for effective treatments is some of the factors promoting the adoption of scaffold technology.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/scaffold-technology-market

Further Key Findings From the Study Suggest:

In 2015, hydrogels-based scaffolds dominated the market with a share of over 41% with respect to revenue generation owing to their higher availability as well as continual progress in their development. Moreover, their promising use as cartilage tissue engineering scaffolds, which enable simultaneous cell growth and drug delivery, is fueling their adoption.
Even though nanofiber-based scaffolds are estimated to exhibit the lowest market penetration in the current scenario, this segment is expected to witness the fastest growth rate in the coming years due to their ability to mimic the nanoscale properties and structural characteristics of native extracellular matrix; this factor is expected to increase their incorporation in regenerative medicine and other clinical applications.
Biotechnology and pharmaceutical organizations held the largest share in 2015 and are expected to witness considerable growth over the forecast period due to the demand for robust tools in metabolic and toxicology profiling of drug moieties during the process of drug development. Also, several biotechnological companies have begun investing in the development of novel products targeting this vertical, which is expected to boost revenue generation through these entities.
In 2014, North America emerged as one of the largest markets. This is attributable to the developed healthcare infrastructure and the presence of a large number of key participants operating in this region. Asia Pacific is expected to be one of the fastest-growing regional segments owing to the rapidly improving infrastructure and favorable government initiatives pertaining to research and development in the pharmaceutical industry.
Some of the key players operating the scaffold technology market include Merck KGaA (Sigma-Aldrich Co. LLC); Thermo Fisher Scientific, Inc.; 3D Biotek LLC; Molecular Matrix, Inc; ReproCELL Europe Ltd (Reinnervate); Xanofi; Pelo Biotech GmbH; Corning, Inc; Becton, Dickinson and Company; 3D Biomatrix; Avacta Life Sciences Limited; Nanofiber Solutions; NuVasive, Inc; Vericel Corporation; Molecular Partners; Acelity (LifeCell Corporation); and Medtronic (Covidien plc).
These players are undertaking different market strategies to maintain their dominance in the market. These strategic endeavors include new product development, acquisitions and mergers, partnerships, and global expansion efforts.
Scaffold technology is considered as the leading candidate employed to perform 3D-culture assays including high throughput screening, cell to matrix interactions, cell to cell interactions, cell migration assays, and transfections, which collectively accounted for the largest segment share in 2015 and is anticipated to witness lucrative growth in the coming years. The significant share is attributed to the increasing use of scaffold technology to study cellular behavior and understand the underlying mechanism of diseases.

Soil Conditioner Market Size Worth $7.9 Billion By 2025

The global soil conditioners market size is projected to reach USD 7.9 billion by 2025, exhibiting a CAGR of 5.7% according to a new report by Grand View Research, Inc. The declining soil quality due to natural calamities and increased industrialization is anticipated to drive the market over the forecast period.

Natural or organic products dominated the consumption of these conditioners globally. Increasing awareness about organic farming has led to an increase in demand for natural conditioners. The rising trend of consuming organic fresh food has shifted the inclination of farmers toward natural conditioners. Cereals and grains also require soil with rich moisture content at the time of sowing, thus, demanding appropriate conditioners.

Farmers, who are the end users of conditioners for soil, belong to low-income group. This factor majorly contributes to the market being price-sensitive. Moreover, prices of the product are highly controlled by manufacturers and may experience minor inflations or deflations due to constant demand and fluctuating raw material availability.

Central & South America market is anticipated to witness moderate growth rate over the forecast period. This can be attributed to the presence of extremely fertile lands in some parts of Argentina, Brazil, Colombia, and Chile, as these lands require less amount of conditioners. A majority area of Central & South America region has a tropical climate, suitable for growing a variety of fruits such as papaya, pineapple, avocado, and guava. Cocoa and coffee are the two major cash crops that largely influence the region’s economy. Most of the region’s land is covered with clay soil, which is alkaline and has a significant demand for minerals such as sulfur and iron.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/soil-conditioners-market

Further key findings from the report suggest:

Loam soil accounted for 396.4 kilotons of soil conditioner consumption volume in 2018, majorly due to its high fertility and wide availability in major parts of the world
Cereals & grains are cultivated on a large scale worldwide and accounted for a total product consumption of 42.6% in 2018
Hydrogel segment is expected to advance at a CAGR of 5.9%, in terms of revenue, from 2019 to 2025 on account of fluctuating water supply and changing weather conditions
India accounted for 16% revenue share in the Asia Pacific market in 2018 owing to growing adoption of precision farming coupled with government subsidies on agricultural products
Key soil conditioner market players offering comprehensive products include BASF SE, Syngenta AG, Solvay S.A., Eastman Soil Amendments, Inc., UPL Limited, and Nufarm.